Discover 1,092 paid clinical trials in South Carolina. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
South Carolina has a wide range of paid research studies actively seeking both healthy volunteers and those with particular health conditions. Major hubs in Charleston, Columbia, and Greenville provide access to innovative treatments and top-quality medical care.
Filter
1
Filter results
Results: 1,092
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
for
Intracranial Meningioma, Recurrent Meningioma,
Location: Boston MA, Hartford CT, New Haven CT,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT02523014
Phase2, Recruiting
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In
for
NSCLC Stage IV
Location: Saint John, Richmond VA, Fairfax VA, Fort Lauderdale FL,
Sponsor: ImmunityBio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06745908
Phase3, Recruiting
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
for
Chronic Kidney Disease and Hypertension
Location: Halifax, Saint John, New Bedford MA, Braintree MA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06742723
Phase3, Recruiting
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
for
Metastatic Renal Cell Carcinoma,
Location: Boston MA, Quebec, Bay Shore NY, Commack NY,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT05327686
Phase2, Recruiting
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Brewer ME, Gloucester MA, South Weymouth MA, Beverly MA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05987241
Phase2, Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate
for
Carcinoma, Squamous Cell
Location: Baltimore MD, Columbia SC, Louisville KY, Dallas TX,
Sponsor: Introgen Therapeutics
Sex: All
Age: 18+
Code: NCT00041613
Phase3, Recruiting
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
for
Colorectal Cancer, Sarcopenia
Location: Millville DE, Rehoboth Beach DE, Wilmington DE,
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 60+
Code: NCT03998202
Recruiting
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Location: Boston MA, Providence RI, Burlington MA, New Haven CT,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06119581
Phase3, Recruiting
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Brewer ME, Boston MA, Providence RI, West Haven CT,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 0+
Code: NCT04242095
Recruiting
A Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC
for
Nonmuscle-invasive Bladder Cancer
Location: New Brunswick NJ, Myrtle Beach SC, Pittsburgh PA,
Sponsor: ImmVira Pharma Co. Ltd
Sex: All
Age: 18+
Code: NCT06971614
Phase2, Recruiting
Systemic Hypothermia in Acute Cervical Spinal Cord Injury
for
Spinal Cord Injury, Acute
Location: Philadelphia PA, Baltimore MD, Miami FL, Columbia SC,
Sponsor: University of Miami
Sex: All
Age: 18 - 70
Code: NCT02991690
Recruiting
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.